Innovative Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Innovative Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Innovative Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Innovative Drug Overall Market Size
2.1 Global Innovative Drug Market Size: 2021 VS 2028
2.2 Global Innovative Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Innovative Drug Players in Global Market
3.2 Top Global Innovative Drug Companies Ranked by Revenue
3.3 Global Innovative Drug Revenue by Companies
3.4 Top 3 and Top 5 Innovative Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Innovative Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Innovative Drug Players in Global Market
3.6.1 List of Global Tier 1 Innovative Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Innovative Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Innovative Drug Market Size Markets, 2021 & 2028
4.1.2 Biological Medicine
4.1.3 Chemical Medicine
4.2 By Type - Global Innovative Drug Revenue & Forecasts
4.2.1 By Type - Global Innovative Drug Revenue, 2017-2022
4.2.2 By Type - Global Innovative Drug Revenue, 2023-2028
4.2.3 By Type - Global Innovative Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Innovative Drug Market Size, 2021 & 2028
5.1.2 Hospitals and Clinics
5.1.3 Pharmacy
5.1.4 Others
5.2 By Application - Global Innovative Drug Revenue & Forecasts
5.2.1 By Application - Global Innovative Drug Revenue, 2017-2022
5.2.2 By Application - Global Innovative Drug Revenue, 2023-2028
5.2.3 By Application - Global Innovative Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Innovative Drug Market Size, 2021 & 2028
6.2 By Region - Global Innovative Drug Revenue & Forecasts
6.2.1 By Region - Global Innovative Drug Revenue, 2017-2022
6.2.2 By Region - Global Innovative Drug Revenue, 2023-2028
6.2.3 By Region - Global Innovative Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Innovative Drug Revenue, 2017-2028
6.3.2 US Innovative Drug Market Size, 2017-2028
6.3.3 Canada Innovative Drug Market Size, 2017-2028
6.3.4 Mexico Innovative Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Innovative Drug Revenue, 2017-2028
6.4.2 Germany Innovative Drug Market Size, 2017-2028
6.4.3 France Innovative Drug Market Size, 2017-2028
6.4.4 U.K. Innovative Drug Market Size, 2017-2028
6.4.5 Italy Innovative Drug Market Size, 2017-2028
6.4.6 Russia Innovative Drug Market Size, 2017-2028
6.4.7 Nordic Countries Innovative Drug Market Size, 2017-2028
6.4.8 Benelux Innovative Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Innovative Drug Revenue, 2017-2028
6.5.2 China Innovative Drug Market Size, 2017-2028
6.5.3 Japan Innovative Drug Market Size, 2017-2028
6.5.4 South Korea Innovative Drug Market Size, 2017-2028
6.5.5 Southeast Asia Innovative Drug Market Size, 2017-2028
6.5.6 India Innovative Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Innovative Drug Revenue, 2017-2028
6.6.2 Brazil Innovative Drug Market Size, 2017-2028
6.6.3 Argentina Innovative Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Innovative Drug Revenue, 2017-2028
6.7.2 Turkey Innovative Drug Market Size, 2017-2028
6.7.3 Israel Innovative Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Innovative Drug Market Size, 2017-2028
6.7.5 UAE Innovative Drug Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Innovative Drug Major Product Offerings
7.1.4 Pfizer Innovative Drug Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Innovative Drug Major Product Offerings
7.2.4 Roche Innovative Drug Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Innovative Drug Major Product Offerings
7.3.4 Sanofi Innovative Drug Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Innovative Drug Major Product Offerings
7.4.4 Johnson & Johnson Innovative Drug Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Merck & Co. (MSD)
7.5.1 Merck & Co. (MSD) Corporate Summary
7.5.2 Merck & Co. (MSD) Business Overview
7.5.3 Merck & Co. (MSD) Innovative Drug Major Product Offerings
7.5.4 Merck & Co. (MSD) Innovative Drug Revenue in Global Market (2017-2022)
7.5.5 Merck & Co. (MSD) Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Innovative Drug Major Product Offerings
7.6.4 Novartis Innovative Drug Revenue in Global Market (2017-2022)
7.6.5 Novartis Key News
7.7 AbbVie
7.7.1 AbbVie Corporate Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Innovative Drug Major Product Offerings
7.7.4 AbbVie Innovative Drug Revenue in Global Market (2017-2022)
7.7.5 AbbVie Key News
7.8 Gilead Sciences
7.8.1 Gilead Sciences Corporate Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Innovative Drug Major Product Offerings
7.8.4 Gilead Sciences Innovative Drug Revenue in Global Market (2017-2022)
7.8.5 Gilead Sciences Key News
7.9 GlaxoSmithKline (GSK)
7.9.1 GlaxoSmithKline (GSK) Corporate Summary
7.9.2 GlaxoSmithKline (GSK) Business Overview
7.9.3 GlaxoSmithKline (GSK) Innovative Drug Major Product Offerings
7.9.4 GlaxoSmithKline (GSK) Innovative Drug Revenue in Global Market (2017-2022)
7.9.5 GlaxoSmithKline (GSK) Key News
7.10 Amgen
7.10.1 Amgen Corporate Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Innovative Drug Major Product Offerings
7.10.4 Amgen Innovative Drug Revenue in Global Market (2017-2022)
7.10.5 Amgen Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca Business Overview
7.11.3 AstraZeneca Innovative Drug Major Product Offerings
7.11.4 AstraZeneca Innovative Drug Revenue in Global Market (2017-2022)
7.11.5 AstraZeneca Key News
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Corporate Summary
7.12.2 Bristol-Myers Squibb Business Overview
7.12.3 Bristol-Myers Squibb Innovative Drug Major Product Offerings
7.12.4 Bristol-Myers Squibb Innovative Drug Revenue in Global Market (2017-2022)
7.12.5 Bristol-Myers Squibb Key News
7.13 Eli Lilly
7.13.1 Eli Lilly Corporate Summary
7.13.2 Eli Lilly Business Overview
7.13.3 Eli Lilly Innovative Drug Major Product Offerings
7.13.4 Eli Lilly Innovative Drug Revenue in Global Market (2017-2022)
7.13.5 Eli Lilly Key News
7.14 Teva
7.14.1 Teva Corporate Summary
7.14.2 Teva Business Overview
7.14.3 Teva Innovative Drug Major Product Offerings
7.14.4 Teva Innovative Drug Revenue in Global Market (2017-2022)
7.14.5 Teva Key News
7.15 Bayer
7.15.1 Bayer Corporate Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Innovative Drug Major Product Offerings
7.15.4 Bayer Innovative Drug Revenue in Global Market (2017-2022)
7.15.5 Bayer Key News
7.16 Novo Nordisk
7.16.1 Novo Nordisk Corporate Summary
7.16.2 Novo Nordisk Business Overview
7.16.3 Novo Nordisk Innovative Drug Major Product Offerings
7.16.4 Novo Nordisk Innovative Drug Revenue in Global Market (2017-2022)
7.16.5 Novo Nordisk Key News
7.17 Allergan
7.17.1 Allergan Corporate Summary
7.17.2 Allergan Business Overview
7.17.3 Allergan Innovative Drug Major Product Offerings
7.17.4 Allergan Innovative Drug Revenue in Global Market (2017-2022)
7.17.5 Allergan Key News
7.18 Takeda
7.18.1 Takeda Corporate Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Innovative Drug Major Product Offerings
7.18.4 Takeda Innovative Drug Revenue in Global Market (2017-2022)
7.18.5 Takeda Key News
7.19 Boehringer Ingelheim
7.19.1 Boehringer Ingelheim Corporate Summary
7.19.2 Boehringer Ingelheim Business Overview
7.19.3 Boehringer Ingelheim Innovative Drug Major Product Offerings
7.19.4 Boehringer Ingelheim Innovative Drug Revenue in Global Market (2017-2022)
7.19.5 Boehringer Ingelheim Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Innovative Drug Market Opportunities & Trends in Global Market
Table 2. Innovative Drug Market Drivers in Global Market
Table 3. Innovative Drug Market Restraints in Global Market
Table 4. Key Players of Innovative Drug in Global Market
Table 5. Top Innovative Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Innovative Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Innovative Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Innovative Drug Product Type
Table 9. List of Global Tier 1 Innovative Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Innovative Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Innovative Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Innovative Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Innovative Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Innovative Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Innovative Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Innovative Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Innovative Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Innovative Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Innovative Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Innovative Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Innovative Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Innovative Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Innovative Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Innovative Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Innovative Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Innovative Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Innovative Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Innovative Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Innovative Drug Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Innovative Drug Product Offerings
Table 32. Pfizer Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Innovative Drug Product Offerings
Table 35. Roche Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Innovative Drug Product Offerings
Table 38. Sanofi Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Innovative Drug Product Offerings
Table 41. Johnson & Johnson Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 42. Merck & Co. (MSD) Corporate Summary
Table 43. Merck & Co. (MSD) Innovative Drug Product Offerings
Table 44. Merck & Co. (MSD) Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Innovative Drug Product Offerings
Table 47. Novartis Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 48. AbbVie Corporate Summary
Table 49. AbbVie Innovative Drug Product Offerings
Table 50. AbbVie Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 51. Gilead Sciences Corporate Summary
Table 52. Gilead Sciences Innovative Drug Product Offerings
Table 53. Gilead Sciences Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline (GSK) Corporate Summary
Table 55. GlaxoSmithKline (GSK) Innovative Drug Product Offerings
Table 56. GlaxoSmithKline (GSK) Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 57. Amgen Corporate Summary
Table 58. Amgen Innovative Drug Product Offerings
Table 59. Amgen Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 60. AstraZeneca Corporate Summary
Table 61. AstraZeneca Innovative Drug Product Offerings
Table 62. AstraZeneca Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 63. Bristol-Myers Squibb Corporate Summary
Table 64. Bristol-Myers Squibb Innovative Drug Product Offerings
Table 65. Bristol-Myers Squibb Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 66. Eli Lilly Corporate Summary
Table 67. Eli Lilly Innovative Drug Product Offerings
Table 68. Eli Lilly Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 69. Teva Corporate Summary
Table 70. Teva Innovative Drug Product Offerings
Table 71. Teva Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 72. Bayer Corporate Summary
Table 73. Bayer Innovative Drug Product Offerings
Table 74. Bayer Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 75. Novo Nordisk Corporate Summary
Table 76. Novo Nordisk Innovative Drug Product Offerings
Table 77. Novo Nordisk Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 78. Allergan Corporate Summary
Table 79. Allergan Innovative Drug Product Offerings
Table 80. Allergan Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 81. Takeda Corporate Summary
Table 82. Takeda Innovative Drug Product Offerings
Table 83. Takeda Innovative Drug Revenue (US$, Mn), (2017-2022)
Table 84. Boehringer Ingelheim Corporate Summary
Table 85. Boehringer Ingelheim Innovative Drug Product Offerings
Table 86. Boehringer Ingelheim Innovative Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Innovative Drug Segment by Type in 2021
Figure 2. Innovative Drug Segment by Application in 2021
Figure 3. Global Innovative Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Innovative Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Innovative Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Innovative Drug Revenue in 2021
Figure 8. By Type - Global Innovative Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Innovative Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Innovative Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Innovative Drug Revenue Market Share, 2017-2028
Figure 12. US Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Innovative Drug Revenue Market Share, 2017-2028
Figure 16. Germany Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Innovative Drug Revenue Market Share, 2017-2028
Figure 24. China Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Innovative Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Innovative Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Innovative Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck & Co. (MSD) Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AbbVie Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Gilead Sciences Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline (GSK) Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Amgen Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. AstraZeneca Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bristol-Myers Squibb Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Eli Lilly Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Teva Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Bayer Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Novo Nordisk Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Allergan Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Takeda Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Boehringer Ingelheim Innovative Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
